Evidence map›Paper›PMID 32329376›Full record

ArticleDrug delivery2020

PLGA microsphere-based composite hydrogel for dual delivery of ciprofloxacin and ginsenoside Rh2 to treat

Minghao Sun, Chune Zhu, Jieyu Long, Chao Lu, Xin Pan, Chuanbin Wu

Open access · goldAbstract read
In one paragraph

Article in Drug delivery, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 22 papers.

0numbers the graph read from it
0cells of the map it votes in
22citing papers in PubMed
3.1field-weighted citation impact, top 7% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

22 citing papers in PubMed, 58 citations in OpenAlex.

  1. Review
  2. Review
  3. Review
  4. Article
  5. Review
  6. Nutrients · 2024
    Review
  7. Influence ofFoods (Basel, Switzerland) · 2023
    Article
  8. Review
  9. Review
  10. Review
  11. Article
  12. Article
  13. Ginsenosides fromInternational journal of molecular sciences · 2023
    Review
  14. HPharmaceutics · 2023
    Article
  15. Overview of Antimicrobial Biodegradable Polyester-Based Formulations.International journal of molecular sciences · 2023
    Review
  16. Article
  17. Review
  18. Article
  19. Review
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 2 institutions in 1 country.

Minghao SunSchool of Pharmaceutical Sciences, Sun Yat-sen University, Guangzhou, China.
Chune ZhuSchool of Traditional Chinese Medicine, Guangdong Pharmaceutical University, Guangzhou, China.
Jieyu LongSchool of Pharmaceutical Sciences, Sun Yat-sen University, Guangzhou, China.
Chao LuSchool of Pharmaceutical Sciences, Sun Yat-sen University, Guangzhou, China.ORCID https://orcid.org/0000-0002-2118-8888
Xin PanSchool of Pharmaceutical Sciences, Sun Yat-sen University, Guangzhou, China.ORCID https://orcid.org/0000-0003-1437-2780
Chuanbin WuSchool of Pharmaceutical Sciences, Sun Yat-sen University, Guangzhou, China.ORCID http://orcid.org/0000-0003-1661-0201
Sun Yat-sen University · CNGuangdong Pharmaceutical University · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

When antibiotic-resistant pathogenic bacteria pose a high threat to human health, bacterial multidrug efflux pumps become major contributors to the high-level antibiotic resistance in most microorganisms. Since traditional antibiotics are still indispensable currently, we report a dual drug delivery system to maximize the antibacterial efficacy of antibiotics by inhibiting efflux pumps in bacteria before their exposure to antibiotics. In this research, a microsphere/hydrogel composite was constructed from ciprofloxacin (Cip)-loaded poly (lactic-

Indexed as

HydrogelsPolylactic Acid-Polyglycolic Acid CopolymerAdministration, CutaneousAnimalsAnti-Bacterial AgentsCiprofloxacinDrug Delivery SystemsDrug LiberationDrug Resistance, Multiple, BacterialDrug SynergismDrug Therapy, CombinationGinsenosidesHaCaT CellsHumansMethicillin-Resistant Staphylococcus aureusMiceAnti-Bacterial AgentsCiprofloxacinginsenoside Rh2GinsenosidesHydrogelsPolylactic Acid-Polyglycolic Acid CopolymerCiprofloxacinginsenoside Rh2microsphere/hydrogel compositesequential releaseskin infections

Identifiers

PMID32329376
PMCPMC7241502
OpenAlexW3020247372

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.